Neurocrine Biosciences, Inc. (NBIX) Social Stream
NEUROCRINE BIOSCIENCES INC (NBIX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering NEUROCRINE BIOSCIENCES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 20 | $150 | $100 | $123.421 | $113.11 | 9.12% |
| 2021-11-17 | 20 | $150 | $100 | $123.222 | $113.11 | 8.94% |
| 2021-11-19 | 20 | $150 | $76 | $120.736 | $113.11 | 6.74% |
| 2021-12-07 | 21 | $150 | $76 | $120.736 | $113.11 | 6.74% |
| 2022-01-07 | 22 | $154 | $76 | $122 | $113.11 | 7.86% |
| 2022-01-10 | 22 | $154 | $76 | $121.789 | $113.11 | 7.67% |
| 2022-01-18 | 22 | $154 | $76 | $120.263 | $113.11 | 6.32% |
| 2022-01-26 | 22 | $154 | $76 | $119.052 | $113.11 | 5.25% |
| 2022-01-30 | 22 | $154 | $76 | $117.157 | $113.11 | 3.58% |
| 2022-01-31 | 22 | $154 | $76 | $116.736 | $113.11 | 3.21% |
| 2022-02-14 | 21 | $154 | $76 | $116.473 | $113.11 | 2.97% |
| 2022-02-16 | 21 | $150 | $76 | $116.473 | $113.11 | 2.97% |
| 2022-02-25 | 21 | $150 | $76 | $115.65 | $113.11 | 2.25% |
| 2022-03-03 | 21 | $150 | $76 | $114.6 | $113.11 | 1.32% |
| 2022-04-12 | 20 | $150 | $76 | $114.65 | $113.11 | 1.36% |
| 2022-04-21 | 19 | $150 | $76 | $114.55 | $113.11 | 1.27% |
| 2022-05-04 | 20 | $150 | $76 | $114.8 | $113.11 | 1.49% |
| 2022-05-05 | 20 | $150 | $76 | $114.6 | $113.11 | 1.32% |
| 2022-05-06 | 19 | $150 | $76 | $114.4 | $113.11 | 1.14% |
| 2022-05-10 | 19 | $150 | $76 | $114.368 | $113.11 | 1.11% |
| 2022-06-02 | 19 | $150 | $76 | $114.315 | $113.11 | 1.07% |
| 2022-06-06 | 19 | $150 | $76 | $113.578 | $113.11 | 0.41% |
| 2022-08-01 | 19 | $150 | $76 | $113.736 | $113.11 | 0.55% |
| 2022-08-05 | 20 | $150 | $76 | $114.052 | $113.11 | 0.83% |
| 2022-08-13 | 20 | $150 | $76 | $114.5 | $113.11 | 1.23% |
| 2022-08-18 | 20 | $150 | $76 | $114.9 | $113.11 | 1.58% |
| 2022-09-21 | 20 | $150 | $76 | $115.55 | $113.11 | 2.16% |
| 2022-09-26 | 20 | $150 | $76 | $115.285 | $113.11 | 1.92% |
| 2022-10-11 | 21 | $150 | $76 | $116.227 | $113.11 | 2.76% |
| 2022-10-13 | 21 | $150 | $76 | $116.818 | $113.11 | 3.28% |
| 2022-10-20 | 22 | $150 | $76 | $116.304 | $113.11 | 2.82% |
| 2022-10-21 | 22 | $150 | $76 | $116.347 | $113.11 | 2.86% |
| 2022-10-24 | 21 | $150 | $76 | $116.608 | $113.11 | 3.09% |
| 2022-11-02 | 21 | $150 | $91 | $121.478 | $113.11 | 7.4% |
| 2022-11-03 | 21 | $150 | $101 | $125.391 | $113.11 | 10.86% |
| 2022-11-14 | 22 | $150 | $101 | $126.043 | $113.11 | 11.43% |
| 2023-01-17 | 21 | $150 | $101 | $126.043 | $113.11 | 11.43% |
| 2023-01-26 | 21 | $150 | $101 | $126.13 | $113.11 | 11.51% |
| 2023-01-30 | 21 | $150 | $101 | $126 | $113.11 | 11.4% |
| 2023-02-07 | 21 | $150 | $101 | $126.739 | $113.11 | 12.05% |
| 2023-02-08 | 21 | $150 | $95 | $126.043 | $113.11 | 11.43% |
| 2023-02-13 | 21 | $150 | $95 | $126.956 | $113.11 | 12.24% |
| 2023-02-23 | 21 | $150 | $95 | $126.217 | $113.11 | 11.59% |
| 2023-04-05 | 21 | $150 | $95 | $126.217 | $113.11 | 11.59% |
| 2023-04-12 | 21 | $150 | $95 | $125.739 | $113.11 | 11.17% |
| 2023-04-17 | 21 | $150 | $95 | $125.608 | $113.11 | 11.05% |
| 2023-04-20 | 21 | $150 | $95 | $125.434 | $113.11 | 10.9% |
| 2023-05-01 | 21 | $150 | $95 | $125.391 | $113.11 | 10.86% |
| 2023-05-05 | 23 | $150 | $95 | $123.956 | $113.11 | 9.59% |
| 2023-06-01 | 23 | $150 | $95 | $124.166 | $113.11 | 9.77% |
| 2023-06-06 | 23 | $150 | $95 | $123.333 | $113.11 | 9.04% |
| 2023-07-06 | 24 | $150 | $95 | $123.208 | $113.11 | 8.93% |
| 2023-07-14 | 24 | $150 | $95 | $122.916 | $113.11 | 8.67% |
| 2023-07-27 | 24 | $150 | $95 | $122.916 | $113.11 | 8.67% |
| 2023-08-02 | 24 | $150 | $95 | $123 | $113.11 | 8.74% |
| 2023-08-03 | 25 | $150 | $95 | $123.833 | $113.11 | 9.48% |
| 2023-08-22 | 24 | $154 | $95 | $124.913 | $113.11 | 10.43% |
| 2023-09-07 | 24 | $154 | $95 | $125.26 | $113.11 | 10.74% |
| 2023-09-13 | 25 | $154 | $95 | $127.166 | $113.11 | 12.43% |
The Trend in the Analyst Price Target
NBIX's average price target has moved up $11.35 over the prior 17 months.
NBIX reports an average of 18.59% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-10-24 | 21 | 150 | 76 | 116.608 | 110.11 | 5.9% |
| 2023-02-13 | 21 | 150 | 95 | 126.956 | 103.52 | 22.64% |
| 2023-04-12 | 21 | 150 | 95 | 125.739 | 102.96 | 22.12% |
| 2023-08-02 | 24 | 150 | 95 | 123.000 | 104.14 | 18.11% |
| 2023-08-03 | 25 | 150 | 95 | 124.347 | 103.29 | 20.39% |
NBIX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.44 | 19 | 1 | 5 | 0 | 0 | 25 |
The Trend in the Broker Recommendations
Over the past 18 months, NBIX's average broker recommendation rating improved by 0.47.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- NBIX has a higher number of analysts covering the stock than 7084.16% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, NEUROCRINE BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 855.94% of them.
- NEUROCRINE BIOSCIENCES INC's average analyst price target is greater than 6587.45% of Pharmaceutical Products stocks.
- NBIX has a lower variance in analysts' estimates than -4655.25% of stocks in the large market cap category.
In the Pharmaceutical Products industry, TECH, RGEN, and DNA are the three stocks most similar to NEUROCRINE BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding NBIX using the data that counts. Try POWR Ratings for free.